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1. Introduction  
An automobile starts and runs. In much the same way, colorectal cancer starts and runs but 
our understanding of how this happens is incomplete. The disease affects millions of men 
and women around the world, and is responsible for significant morbidity and mortality in 
patients. Increasing numbers of new cases continue to appear worldwide and there is little 
evidence of a decline in incidence of the disease. The necessity for improved management 
and treatment of colorectal cancer in patients continues to drive studies and investigations 
towards a better understanding of the origins of the disease. Much of the evidence suggests 
that the origins of colorectal cancer are multifactorial: genetic and environmental factors 
intertwine with risk factors. Figure 1 lays out various aspects of colorectal cancer that 
provide broad focal points for studies and research investigations. In vitro studies have 
helped to define the scientific knowledge base regarding initiation of colorectal cancer and 
the mechanisms that sustain progression and encourage spread of the disease. Clinical 
studies and trials have provided insights into disease management and patient care. Animal 
modeling provides an important bridge between in vitro studies and investigations in 
patients. So what is the current state of the evidence regarding the causes and biological 
mechanisms involved in colorectal cancer? While the chapters in this volume of the book 
deliver detailed overviews of various aspects of the basic science involved in our 
understanding of the disease, this introductory chapter offers a summary outline of some of 
the evidence. 
2. Genes and heredity 
Genetic and hereditary mechanisms have a significant influence on colorectal cancer. 
Studies indicate that familial history plays a role in up to 25% of patients who are diagnosed 
with colorectal cancer (Gala & Chung, 2011) and this helps to explain the origins of their 
disease. Several genes have been implicated in the process of colorectal carcinogenesis 
including adenomatous polyposis coli (APC), rat sarcoma oncogene K-ras, tumor 
suppressor TP53, DNA glycosylase gene MUTYH, and murine sarcoma oncogene BRAF. In 
many patients, the most frequently mutated gene is the APC gene (Bettstetter et al, 2007; 
Vasovcak et al, 2011). Some of the methods by which these genes are affected include 
hypermethylation of promoter sequences for tumor suppressor genes as well as the 
induction of microsatellite instability. About 15% of colorectal cancers show microsatellite 
instability from mutated mismatch repair genes (Pino & Chung, 2011). 
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A majority of colorectal cancers are associated with colonic polyposis. Familial adenomatous 
polyposis (FAP) confers a genetic predisposition to developing multiple benign polyps in 
the large intestine, a reflection of the inherited mutation in the APC gene. Polyps eventually 
progress to malignant colorectal cancer. Patients with Lynch Syndrome have a genetic 
predisposition that confers a high risk for developing early onset, right-sided colorectal 
cancer (Bellizzi & Frankel, 2009). More recently recognized syndromes also include 
MUTYH-associated polyposis (MAP), and hyperplastic polyposis syndromes which show 
mutations of K-ras and microsatellite instability – changes similar to those associated with 
colorectal cancer (Hawkins et al, 2000; Jass et al, 2000; Liljegren et al, 2003). 
 
 
Fig. 1. The aspects of colorectal cancer that drive the quest for improved understanding, 
better management, effective therapies, and prevention. Aspects of initiation and 
mechanisms are considered in this volume of the book. Management, diagnosis and 
epidemiological considerations are dealt with in the second volume of the book. 
Animal models of colorectal cancer have contributed to improving understanding of the 
disease. The APC min mouse model develops multiple intestinal polyps and illustrates the 
role of Wnt signaling and beta catenin regulation in the formation of these polyps 
(Kawahara et al, 2000; Senda et al, 2007). The model provides one avenue for testing and 
evaluating pharmacotherapeutic approaches in colorectal cancer. 
3. Nutrition 
The relationship between nutrition and colorectal cancer remains inconsistent and 
debatable. Some studies suggest variable colorectal cancer risk with ingestion of fruit and 
vegetables, other studies indicate a reduction in the risk (Millen et al, 2007; Koushik et al, 
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2007; Anemma et al, 2011). The evidence is just as conflicting even when specific food 
components such as folate are considered (Mason, 2011). Some of the published data 
supports the association between colorectal cancer and processed foods as well as with 
consumption of red meat: the risk of colorectal cancer increases in line with increasing 
intake (Fu et al, 2011; Gingras and Beliveau, 2011). In addition, the risk among heavy alcohol 
drinkers for developing colorectal cancer is considerably higher than the risk for those 
whose alcohol intake is low (Pelluchi et al, 2011). 
4. Mechanisms 
The role of inflammation in colorectal cancer is demonstrated by the increased risk of 
colorectal in patients with chronic inflammatory conditions: the risk in patients with 
ulcerative colitis is 2-fold higher than for the general population and up to 0.8% of patients 
with Crohn's disease develop colorectal cancer (Pohl et al, 2000; Rizzo et al, 2011). These 
inflammatory diseases also demonstrate genetic alterations in some of the same targets 
associated with colorectal cancer. In addition, anti-inflammatory therapy significantly 
reduces the risk of colorectal cancer (Trinchieri, 2011).  
The intestine is colonized by great numbers of microbes in a symbiotic relationship with the 
gut epithelium, a relationship that affects digestion, absorption and nutrition. Nonetheless, 
there is increasing evidence of the association between intestinal streptococcal infection and 
colorectal cancer. However the precise mechanism by which these streptococcal strains are 
involved in the development or propagation of colorectal cancer remains unclear (Boleij et 
al, 2011). Enteric microbes are thought to alter normal regulatory mechanisms in epithelial 
cells to promote disruption and tumor growth (Wu et al, 2003; Sun et al, 2004; Franco et al, 
2005; Ye et al, 2007; Suzuki et al, 2009; Gnad et al, 2010; Liu et al, 2010).  
The idea that colorectal cancer is sustained by stem cells that continually supply new tumor 
cells continues to spur research investigations and generate new data. The idea however 
remains controversial despite several reports presenting data on putative cell surface 
markers for these stem cells. Isolated colorectal cancer stem cells (initiating cells) express a 
variety of cluster of differentiation proteins or markers that suggest a multipotent ability 
(Willis et al, 2008; Kemper et al, 2010; Davies et al, 2011; Zeki et al, 2011) but identification of 
a reliable stem cell biomarker is still elusive. These cells offer a potential target for cure of 
the disease in patients and for the control of metastatic spread that is thought to arise from 
residual stem cells that survive therapy for the primary tumor. 
5. Conclusion 
Our understanding of colorectal cancer in terms of origination, genesis, initiating causes and 
progression continues to improve. While multiple factors contribute to and influence the 
initiation and progression of the disease, the number of potential targets continues to increase. 
This targeting potential will ultimately lead to the development of effective strategies for 
management of the disease and translate into improved treatments for patients. 
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